(openPR) - New Analysis by Applied Data Research Examines Clinical Developments and Assesses Healthcare Impact
(Nashua, NH) – The recent impact of biological drugs in the treatment of serious illnesses has had a dramatic effect on therapeutic outcomes for previously refractory conditions and created needed commercial successes for pharmaceutical companies. In recent years, the number of biological pharmaceuticals reaching the marketplace has increased exponentially. But the complex structure of these therapeutic substances require special formulation and delivery strategies, creating special challenges for drug developers and their formulation technology and delivery device partners.
Drug companies are making adjustments to address key development factors. Cooperation between device designers and drug developers is occurring much earlier in the drug development cycle, allowing device designs in many cases to be tailored to the bioavailability targets and pharmacokinetic profiles of specific drug therapies. The new devices – a group that includes pen injectors and dry powder inhalers - are typically patient-friendly, easing compliance concerns, which have a non-negligible effect on drug formulations and delivery decisions, and are becoming a significant factor in the prescribing decisions of many physicians.
While injection will remain the dominant route of administration for biological drugs for the rest of the decade, the recent clinical success of several alternative biological delivery methods will result in escalating interest in these areas. Work on stabilized oral formulations is also making progress.
These are some of the finds of a recent survey, the results of which are contained in a comprehensive report – Biological Drug Delivery: Drugs, Devices and Disease Therapeutics.
Applied Data Research
98 Route 101A
Amehrst, NH 03031 USA
Greg Stone
Voice: 603-595-4340 www.applieddata.org
About Applied Data
Applied Data Research is a healthcare therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis.
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
Newsfeed
